stockrowLantheus Holdings, Inc.
LNTH Healthcare Drug Manufacturers Specialty & Generic
Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024.
- Revenue
- +1.54%
- EPS
- −17.1%
- Free cash flow
- +7.71%
- Total debt
- +0.52%
Quarter to September 2026, against a year earlier
Follow LNTH
Alert me
Lantheus Holdings, Inc. (LNTH) Revenue growth
Lantheus Holdings, Inc.'s revenue growth over the twelve months to 30 September 2026 was 2.38%, up 1.9 percentage points from fiscal 2025 (0.50%). Over the past ten years it has ranged from −2.70% (fiscal 2015) to 119.9% (fiscal 2022); the current reading is higher than 27% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 5.22% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 0.50% | (17.82) |
| FY2024 | 18.3% | (20.33) |
| FY2023 | 38.7% | (81.26) |
| FY2022 | 119.9% | 94.63 |
| FY2021 | 25.3% | 27.56 |
| FY2020 | −2.28% | (3.43) |
| FY2019 | 1.15% | (2.47) |
| FY2018 | 3.62% | (6.16) |
| FY2017 | 9.78% | 6.92 |
| FY2016 | 2.86% | 5.56 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 1.54% | (1.14) |
| Jun 2026 | 2.68% | 1.45 |
| Mar 2026 | 1.23% | (2.78) |
| Dec 2025 | 4.01% | 2.62 |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| LQDA Liquidia Corporation compare | 2,233.7% |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 58.2% |
| HIMS Hims & Hers Health, Inc. compare | 28.0% |
| SUPN Indivior Pharmaceuticals Inc. compare | 16.4% |
| ALKS Alkermes plc compare | 15.3% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 8.88% |
| LNTH Lantheus Holdings, Inc. | 2.38% |
| RDY Dr. Reddy's Laboratories Ltd compare | −15.5% |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −77.1% |
| Drug Manufacturers Specialty & Generic industry median | 5.22% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on LNTH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement